Ceritinib/crizotinibDevelopment of resistance in EML4-ALK-positive non-small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1635卷 / 1期
关键词：
D O I：
10.1007/s40278-017-25324-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 75
相关论文
共 50 条
  • [1] Alectinib/crizotinibDevelopment of drug resistance in ALK-positive non-small cell lung cancer: case report
    Reactions Weekly, 2020, 1829 (1) : 23 - 23
  • [2] Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK-Positive Non-Small Cell Lung Cancer
    Tanizaki, Junko
    Okamoto, Isamu
    Okabe, Takafumi
    Sakai, Kazuko
    Tanaka, Kaoru
    Hayashi, Hidetoshi
    Kaneda, Hiroyasu
    Takezawa, Ken
    Kuwata, Kiyoko
    Yamaguchi, Haruka
    Hatashita, Erina
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    CLINICAL CANCER RESEARCH, 2012, 18 (22) : 6219 - 6226
  • [3] Chemosensitivity and clinical features of EML4-ALK-positive patients with advanced non-small cell lung cancer
    Park, Jangchul
    Kondo, Chiaki
    Shimizu, Junichi
    Horio, Yoshitsugu
    Yoshida, Kimihide
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    Hida, Toyoaki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2017, 1633 (1) : 231 - 231
  • [5] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2019, 1754 (1) : 120 - 120
  • [6] Activation of HER Family signaling as a mechanism of acquired resistance to ALK Inhibitors in EML4-ALK-positive Non-Small Cell Lung Cancer.
    Tanizaki, Junko
    Okamoto, Isamu
    Okabe, Takafumi
    Sakai, Kazuko
    Tanaka, Kaoru
    Hayashi, Hidetoshi
    Kaneda, Hiroyasu
    Takezawa, Ken
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    CANCER RESEARCH, 2013, 73 (08)
  • [7] SEVERE ACUTE INTERSTITIAL LUNG DISEASE IN EML4-ALK-POSITIVE NON-SMALL CELL LUNG CANCER TREATED WITH CRIZOTINIB
    Andarini, Sita
    Sahli, Felly
    Pangestu, Hendri
    RESPIROLOGY, 2014, 19 : 148 - 148
  • [8] CrizotinibDevelopment of drug resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2018, 1733 (1) : 121 - 121
  • [9] Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4-ALK-Positive Human Non-Small Cell Lung Cancer
    Pyo, Kyoung Ho
    Lim, Sun Min
    Kim, Hye Ryun
    Sung, Young Hoon
    Yun, Mi Ran
    Kim, Sung-Moo
    Kim, Hwan
    Kang, Han Na
    Lee, Ji Min
    Kim, Sang Gyun
    Park, Chae Won
    Chang, Hyun
    Shim, Hyo Sup
    Lee, Han-Woong
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 491 - 500
  • [10] A Novel Mass Spectrometry-Based Assay for Diagnosis of EML4-ALK-Positive Non-Small Cell Lung Cancer
    Sakai, Kazuko
    Okamoto, Isamu
    Takezawa, Ken
    Hirashima, Tomonori
    Kaneda, Hiroyasu
    Takeda, Masayuki
    Matsumoto, Kazuko
    Kimura, Hideharu
    Fujita, Yoshihiko
    Nakagawa, Kazuhiko
    Arao, Tokuzo
    Nishio, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (05) : 913 - 918
12345